Has Glen Crawford, MD received payments from drug or device companies?

Yes. Drug and device makers reported $98,477 in general payments to Glen Crawford, MD across 376 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Glen Crawford, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Glen Crawford, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Glen Crawford, MD

Dermatology · Philadelphia, PANPI 1598780165

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $88,810 of the $98,477 with a category attached, or 90.2%. 25 manufacturers reported payments, led by AbbVie at 39.2% of the total. Reporting peaked in 2019 at $64,991 and has fallen 98.4% since, to $1,019 in 2025. Among dermatology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$98,477in general payments, 2019–2025

Across 376 payments — averaging $261.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$39K
Regeneron Healthcare Solutions, Inc.$31K
Sanofi$27K
Novartis$369
Johnson & Johnson$318
Pfizer$251
plus $1K from 19 others

What the payments were for

Speaking & faculty fees$88,81090%
Travel & lodging$1,9132%
Food & beverage$7,7058%
Education$500%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	171	$38,645
Regeneron Healthcare Solutions, Inc.	52	$30,549
Sanofi	22	$26,922
Novartis	17	$369
Johnson & Johnson	25	$318
Pfizer	13	$251
Incyte Corporation	11	$236
Sun Pharmaceutical Industries Inc.	8	$165
Lilly USA, LLC	8	$138
Galderma Laboratories, L.p.	7	$114
UCB, Inc.	6	$108
LEO Pharma Inc.	5	$86
Amgen	5	$86
Dermavant Sciences, Inc.	4	$78
Arcutis Biotherapeutics, Inc.	3	$56
Organon	4	$52
Bristol Myers Squibb	2	$45
E.r. Squibb & Sons, L.L.C.	2	$44
Botanix SB Inc	2	$43
DUSA Pharmaceuticals, Inc.	2	$43
Boehringer Ingelheim	1	$31
Journey Medical Corporation	2	$28
Ortho Dermatologics, A Division Of Bausch Health US, LLC	2	$27
Aclaris Therapeutics, Inc.	1	$22
Biofrontera Inc.	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

DUPIXENT$56,265
Humira$18,614
Skyrizi$13,999
Rinvoq$122

How this compares

$98,477 in reported general payments places this provider in the 95th percentile of 626 dermatology providers in Pennsylvania.

See all dermatology providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$245,159

Medicare patients

828

Services billed

4,090

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent PenDupilumab	28	$105,654
Ketoconazole	178	$3,476
Metronidazole	35	$2,612
Clobetasol Propionate	66	$2,232
Calcipotriene	12	$1,701
Triamcinolone Acetonide	106	$1,061
Fluorouracil	18	$995
ValacyclovirValacyclovir Hcl	37	$909
Betamethasone Dipropionate	29	$906
Clindamycin Phosphate	45	$851
Desonide	17	$685
Tretinoin	11	$504
Hydroxychloroquine Sulfate	12	$412
Fluocinolone Acetonide	15	$357
Spironolactone	11	$251

Paid to pharmacies, not to this prescriber.

Other dermatology in Philadelphia

Stephen HessPhiladelphia$1.7M
Joel GelfandPhiladelphia$649K
Victoria WerthPhiladelphia$547K
Nicholas MollanazarPhiladelphia$369K
Harold FarberPhiladelphia$284K
Jules LipoffPhiladelphia$259K
Susan TaylorPhiladelphia$207K
Joy WanPhiladelphia$176K
Harold MilsteinPhiladelphia$120K
David MargolisPhiladelphia$118K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →